| Dr Chu Kai Liang, DDS | |
|
5924 Brookside Oak Cir, Norcross, GA 30093-1752 | |
| (213) 400-0595 | |
| Not Available |
| Full Name | Dr Chu Kai Liang |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 5924 Brookside Oak Cir, Norcross, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003170135 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | DN014431 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chu Kai Liang, DDS 5924 Brookside Oak Cir, Norcross, GA 30093-1752 Ph: (213) 400-0595 | Dr Chu Kai Liang, DDS 5924 Brookside Oak Cir, Norcross, GA 30093-1752 Ph: (213) 400-0595 |
News Archive
A multicenter EPIC (FiberNet- Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet Embolic Protection System (EPS) had a 97.5% success rate when used in patients undergoing carotid artery stenting (CAS). Full findings are published early online in Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions.
An Affordable Care Act provision that allowed young adults to be covered under their parents' insurance led to a shift to earlier-stage diagnosis and more timely receipt of adjuvant chemotherapy among young colorectal cancer patients, according to a new American Cancer Society study. The study appears in JNCI.
Today, Daiichi Sankyo, Inc. received U.S. Food and Drug Administration (FDA) approval to package product at its first United States-based packaging facility located in Bethlehem, PA. With this approval, the Company expands its global supply chain capability, helping to ensure the supply of medicine to U.S. physicians and their patients.
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol for its planned Phase IIb clinical trial for arimoclomol as a treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The decision follows receipt of an anticipated written letter from the U.S.
› Verified 8 days ago
Do Young Chung, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3953 Holcomb Bridge Rd Ste 100, Norcross, GA 30092 Phone: 678-969-5437 | |
Dr. Lauren Crawford Weant, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 3850 Holcomb Bridge Rd Ste 200, Norcross, GA 30092 Phone: 770-447-5311 | |
Dr. Adnan A Hossain, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 3110 Smith Ridge Trce, Norcross, GA 30071 Phone: 646-402-5670 | |
Dr. Hongli Zhao, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 2055 Beaver Ruin Rd Ste E, Norcross, GA 30071 Phone: 770-242-0021 Fax: 770-242-6016 | |
James B Good Child, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 5030 Georgia Belle Ct, Norcross, GA 30093 Phone: 770-638-5708 | |
Dr. Kael A Rogers, DDS, MD Dentist Medicare: Medicare Enrolled Practice Location: 5635 Peachtree Pkwy Ste 100, Norcross, GA 30092 Phone: 404-990-4595 |